SCHEMBL22667351

SCHEMBL22667351

COCCCN1C(=O)C(=O)c2cc(Br)ccc21

nearest known ligand 0.58

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 7/20 0.58
▸ ALDH2 P05091 2/20 0.58
▸ ALDH3A1 P30838 2/20 0.58
▸ CUL4A Q13619 1/20 0.57
▸ ACHE P22303 3/20 0.56
▸ CES1 P23141 1/20 0.56
▸ MAPT P10636 4/20 0.55
▸ KMT2A Q03164 4/20 0.55
▸ MEN1 O00255 3/20 0.55
▸ POLB P06746 3/20 0.55
▸ L3MBTL1 Q9Y468 1/20 0.53
▸ LMNA P02545 2/20 0.52
▸ TDP1 Q9NUW8 2/20 0.52
▸ KDM4E B2RXH2 1/20 0.51
▸ SMN1; SMN2 Q16637 1/20 0.47
▸ RCE1 Q9Y256 1/20 0.47
▸ CASP3 P42574 3/20 0.47
▸ CASP7 P55210 3/20 0.47
▸ CASP1 P29466 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30404925 1.00 ALDH1A1 (0.58) ALDH1A1ALDH2ALDH3A1CUL4AACHE
SCHEMBL22667293 0.92 ALDH1A1 (0.60) ALDH1A1ALDH2ALDH3A1CUL4AACHE
SCHEMBL30404094 0.92 ALDH1A1 (0.60) ALDH1A1ALDH2ALDH3A1CUL4AACHE
SCHEMBL4292310 0.82 CUL4A (0.62) ALDH1A1ALDH2ALDH3A1CUL4AACHE
SCHEMBL29011253 0.82 ALDH1A1 (0.63) ALDH1A1ALDH2ALDH3A1CUL4AACHE
SCHEMBL28606638 0.82 CES1 (0.65) ALDH1A1ALDH2ALDH3A1CUL4AACHE
SCHEMBL11147994 0.81 ALDH1A1 (0.62) ALDH1A1ALDH2ALDH3A1CUL4AACHE
SCHEMBL21001752 0.81 ALDH1A1 (0.65) ALDH1A1ALDH2ALDH3A1CUL4AACHE
SCHEMBL29011247 0.80 ALDH1A1 (0.60) ALDH1A1ALDH2ALDH3A1CUL4AACHE
SCHEMBL16064931 0.80 ALDH1A1 (0.47) ALDH1A1ALDH2ALDH3A1CUL4AACHE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-111433195-B Pyridone derivatives and their use as selective ALK-2 inhibitors 诺华股份有限公司 2023-04-25 — — CN disclosed
US-11160797-B2 Pyridinone derivatives and their use as selective ALK-2 inhibitors NOVARTIS AG (CH) 2021-11-02 — — US disclosed
US-20200360357-A1 Pyridinone derivatives and their use as selective ALK-2 inhibitors NOVARTIS AG (CH) 2020-11-19 — — US disclosed
CN-111433195-A Pyridone derivatives and their use as selective A L K-2 inhibitors 诺华股份有限公司 2020-07-17 — — CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200360357-A1 Pyridinone derivatives and their use as selective ALK-2 inhibitors ALK, ACVR2B, ACVR1B ALDH1A1 118/4885ALDH2 445/4885ALDH3A1 269/4885
US-11160797-B2 Pyridinone derivatives and their use as selective ALK-2 inhibitors ALK, ACVR2B, ACVR1B ALDH1A1 118/4885ALDH2 445/4885ALDH3A1 269/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback